DTC
Deep Track Capital Portfolio holdings
AUM
$3.58B
1-Year Est. Return
45.33%
1 Year Est. Return
+45.33%
AUM
$3.58B
AUM Growth
+$473M
(+15%)
Holding
76
Top Buys
| 1 | +$74.3M | |
| 2 | +$54.7M | |
| 3 | +$52.9M | |
| 4 |
Akero Therapeutics
AKRO
|
+$45.5M |
| 5 |
Cytokinetics
CYTK
|
+$35.7M |
Top Sells
| 1 | +$176M | |
| 2 | +$102M | |
| 3 | +$70.9M | |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
+$49.1M |
| 5 |
Dianthus Therapeutics
DNTH
|
+$41.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORKA
26
Oruka Therapeutics
ORKA
$1.38B
| $51.1M | 1.42% |
2,654,781
+735,983
|
|
||
27
Xenon Pharmaceuticals
XENE
$3.41B
| $48.2M | 1.34% |
1,200,000
-150,000
|
|
||
|
CMPS
28
Compass Pathways
CMPS
$517M
| $45M | 1.26% |
7,859,648
-971,359
|
|
||
29
ANI Pharmaceuticals
ANIP
$1.88B
| $41.2M | 1.15% |
450,000
-250,000
|
|
||
|
BCAX
30
Bicara Therapeutics
BCAX
$998M
| $38.3M | 1.07% |
2,426,657
|
|
||
31
Olema Pharmaceuticals
OLMA
$2.27B
| $34M | 0.95% |
3,470,172
+27,339
|
|
||
32
Cidara Therapeutics
CDTX
$6.92B
| $28.7M | 0.8% |
300,000
+50,000
|
|
||
33
uniQure
QURE
$1.67B
| $28.2M | 0.79% |
+483,092
|
|
||
34
Dyne Therapeutics
DYN
$3.06B
| $25.3M | 0.71% |
+2,000,000
|
|
||
|
JBIO
35
Jade Biosciences
JBIO
$590M
| $19.7M | 0.55% |
2,279,892
-229,409
|
|
||
36
RAPT Therapeutics
RAPT
$887M
| $19.4M | 0.54% |
751,422
|
|
||
37
GH Research
GHRS
$928M
| $17.9M | 0.5% |
1,250,000
-750,000
|
|
||
38
MindMed
MNMD
$1.22B
| $17.7M | 0.49% |
1,500,000
-1,000,000
|
|
||
39
enGene Holdings
ENGN
$530M
| $15.3M | 0.43% |
2,239,353
-2,318,222
|
|
||
40
Genmab
GMAB
$19.8B
| $14.8M | 0.41% |
+481,267
|
|
||
41
Tango Therapeutics
TNGX
$1.42B
| $12.2M | 0.34% |
+1,454,562
|
|
||
42
Context Therapeutics
CNTX
$106M
| $7.19M | 0.2% |
7,419,355
|
|
||
|
IMA
43
ImageneBio Inc
IMA
$79.1M
| $7.16M | 0.2% |
878,516
+668,890
|
|
||
44
Xencor
XNCR
$1.21B
| $6.44M | 0.18% |
549,439
|
|
||
|
CYBN
45
Cybin
CYBN
$307M
| $5.89M | 0.16% |
1,000,000
-529,987
|
|
||
46
CorMedix
CRMD
$759M
| $5.82M | 0.16% |
+500,000
|
|
||
47
PepGen
PEPG
$421M
| $5.54M | 0.15% |
+1,200,000
|
|
||
|
CBIO
48
Crescent Biopharma
CBIO
$251M
| $5.39M | 0.15% |
453,686
|
|
||
49
Aligos Therapeutics
ALGS
$60.9M
| $4.35M | 0.12% |
444,110
|
|
||
|
AUTL
50
Autolus Therapeutics
AUTL
$357M
| $4.19M | 0.12% |
2,568,613
-14,283,534
|
|